Biogen, Inc. (BIIB)
Biogen Market Cap : 27.24B for March 27, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Amgen, Inc. | 189.15B |
| Eli Lilly & Co. | 793.60B |
| Merck & Co., Inc. | 298.24B |
| AbbVie, Inc. | 373.79B |
| Pfizer Inc. | 155.15B |
Market Cap Related Metrics
| PE Ratio | 21.08 |
| PS Ratio | 2.858 |
| Price to Book Value | 1.492 |
| Price to Free Cash Flow | 13.84 |
| Price | 185.63 |
| Earnings Yield | 4.74% |
| Operating PE Ratio | 11.26 |
| Normalized PE Ratio | 15.92 |